Abacavir And Lamivudine 69097-0362-02
- Manufacturer
- Cipla Usa Inc.
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- March 28, 2017
- Listing Expires
- December 31, 2026
- Application
- ANDA091144
Need to source Abacavir And Lamivudine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Abacavir Sulfate | 600 mg/1 |
| Lamivudine | 300 mg/1 |
Drug Class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Cytochrome P450 1A1 Inhibitors [MoA]
Selected Package
69097-0362-02Selected30 TABLET, FILM COATED in 1 BOTTLE (69097-362-02)